{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:29:40Z","timestamp":1785148180207,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Istanbul University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>In this study, we aimed to evaluate the factors affecting the development of damage and mortality in patients with AAV treated at our tertiary referral center. This retrospective study included data on patients with AAV who fulfilled the Chapel Hill Consensus Conference (CHCC) criteria. Patients were divided into c-ANCA\/PR3(\u2009+) and p-ANCA\/MPO (\u2009+) groups based on ANCA immunofluorescence and\/or ELISA results, and relapse, damage, and mortality data were compared across the groups. Data from 254 patients (n\u2009=\u2009136, 53.5% female) were included in the analysis. Clinical diagnosis was GPA in 186 (73.2%) and MPA in 68 (26.8%) patients. During the follow-up, 217 of 242 (89.7%) patients developed damage, and the median VDI score of the cohort was 2 (IQR: 2). VDI scores were higher in the first period (1997\u20132011) than in the second period (2011\u20132021) in the entire cohort (p\u2009=\u20090.012) and in patients with GPA compared with MPA (p\u2009=\u20090.034). Five-year and overall survival rates were 88.1% and 80.3% in the entire cohort; 87.8% and 81% in c-ANCA\/PR3 (\u2009+); 86.2% and 76% in p-ANCA\/MPO (\u2009+) (Log-Rank: p\u2009=\u20090.35); 91% and 84.5% in GPA; 81% and 67.2% in MPA patients (Log-Rank: p\u2009&lt;\u20090.001). Development of malignancy, severe infection, and active\/persistent disease after the induction phase were associated with higher mortality in patients with AAV. In our AAV cohort, permanent organ damage was detected in the majority of the patients. Although the median VDI score decreased over time, mortality did not change.<\/jats:p>","DOI":"10.1007\/s00296-025-05883-7","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T09:33:15Z","timestamp":1746610395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Damage accrual and predictors of mortality in ANCA-associated vasculitis: a retrospective observational study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1788-3837","authenticated-orcid":false,"given":"Murat","family":"Bekta\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9813-2228","authenticated-orcid":false,"given":"Burak","family":"Ince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0952-640X","authenticated-orcid":false,"given":"Sibel","family":"Zaral\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-3585","authenticated-orcid":false,"given":"\u00dcbeyde Ay\u015fe","family":"G\u00fclseren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0343-4886","authenticated-orcid":false,"given":"Ece","family":"\u00dck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3933-1881","authenticated-orcid":false,"given":"Besim Faz\u0131l","family":"A\u011farg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0340-1494","authenticated-orcid":false,"given":"Damla Yenersu","family":"G\u00fczey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9881-6694","authenticated-orcid":false,"given":"Yasemin","family":"Yal\u00e7\u0131nkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5659-3955","authenticated-orcid":false,"given":"Bahar","family":"Art\u0131m-Esen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8219-3720","authenticated-orcid":false,"given":"Ahmet","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6376-5583","authenticated-orcid":false,"given":"Murat","family":"\u0130nan\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"issue":"3","key":"5883_CR1","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/ard.2010.137778","volume":"70","author":"O Flossmann","year":"2011","unstructured":"Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C et al (2011) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70(3):488\u2013494","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"5883_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"RB Jones","year":"2010","unstructured":"Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA et al (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363(3):211\u2013220","journal-title":"N Engl J Med"},{"issue":"9","key":"5883_CR3","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1093\/rheumatology\/kez589","volume":"59","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Fu X, Harkness T, Stone JH, Zhang Y, Choi H (2020) All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type. Rheumatology (Oxford) 59(9):2308\u20132315","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5883_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","volume":"90","author":"L Guillevin","year":"2011","unstructured":"Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Toumelin PL (2011) The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine 90(1):19\u201327","journal-title":"Medicine"},{"key":"5883_CR5","doi-asserted-by":"publisher","first-page":"6369814","DOI":"10.1155\/2018\/6369814","volume":"2018","author":"A Salmela","year":"2018","unstructured":"Salmela A, T\u00f6rnroth T, Poussa T, Ekstrand A (2018) Prognostic factors for survival and relapse in ANCA-associated vasculitis with renal involvement: a clinical long-term follow-up study. Int j nephrol 2018:6369814","journal-title":"Int j nephrol"},{"issue":"8","key":"5883_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006083","volume":"96","author":"R Solans-Laqu\u00e9","year":"2017","unstructured":"Solans-Laqu\u00e9 R, Fraile G, Rodriguez-Carballeira M, Caminal L, Castillo MJ, Mart\u00ednez-Valle F et al (2017) Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity. Medicine 96(8):e6083","journal-title":"Medicine"},{"issue":"1","key":"5883_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1\u201311","journal-title":"Arthritis Rheum"},{"issue":"12","key":"5883_CR8","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S et al (2009) Modification and validation of the Birmingham Vasculitis activity Score (version 3). Ann Rheum Dis 68(12):1827\u20131832","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"5883_CR9","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/art.41773","volume":"73","author":"SA Chung","year":"2021","unstructured":"Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G et al (2021) 2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthr Rheumatol (Hoboken, NJ) 73(8):1366\u20131383","journal-title":"Arthr Rheumatol (Hoboken, NJ)"},{"issue":"6","key":"5883_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/qjmed\/90.6.391","volume":"90","author":"AR Exley","year":"1997","unstructured":"Exley AR, Carruthers DM, Luqmani RA, Kitas GD, Gordon C, Janssen BA et al (1997) Damage occurs early in systemic vasculitis and is an index of outcome. QJM 90(6):391\u2013399","journal-title":"QJM"},{"issue":"9","key":"5883_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612","journal-title":"Ann Intern Med"},{"issue":"10427","key":"5883_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0140-6736(23)01736-1","volume":"403","author":"A Kronbichler","year":"2024","unstructured":"Kronbichler A, Bajema IM, Bruchfeld A, Mastroianni Kirsztajn G, Stone JH (2024) Diagnosis and management of ANCA-associated vasculitis. Lancet (London, England) 403(10427):683\u2013698","journal-title":"Lancet (London, England)"},{"issue":"5","key":"5883_CR13","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00296-021-04802-w","volume":"41","author":"M Aljuhani","year":"2021","unstructured":"Aljuhani M, Makati D, Hoff A, Thompson J, Pellegrino B, Shawwa K et al (2021) Antibody subtypes and titers predict clinical outcomes in ANCA-associated vasculitis. Rheumatol Int 41(5):965\u2013972","journal-title":"Rheumatol Int"},{"issue":"1","key":"5883_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00296-024-05757-4","volume":"45","author":"S Kr\u00e4mer","year":"2024","unstructured":"Kr\u00e4mer S, Vogt K, Schreibing TM, Busch M, Schmitt T, Bergner R et al (2024) Remission induction therapies and long-term outcomes in granulomatosis with polyangiitis and microscopic polyangiitis: real-world data from a European cohort. Rheumatol Int 45(1):7","journal-title":"Rheumatol Int"},{"issue":"3","key":"5883_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00296-023-05272-y","volume":"43","author":"G Alle","year":"2023","unstructured":"Alle G, Scolnik M, Scaglioni V, Gallego JFJ, Varela CF, Greloni G et al (2023) Prognostic factors associated with advanced chronic kidney disease in a cohort of patients with ANCA vasculitis and renal involvement. Rheumatol Int 43(3):487\u2013494","journal-title":"Rheumatol Int"},{"issue":"2","key":"5883_CR16","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3899\/jrheum.090387","volume":"37","author":"S Kamali","year":"2010","unstructured":"Kamali S, Erer B, Artim-Esen B, Gul A, Ocal L, Konice M et al (2010) Predictors of damage and survival in patients with Wegener\u2019s granulomatosis: analysis of 50 patients. J Rheumatol 37(2):374\u2013378","journal-title":"J Rheumatol"},{"issue":"1","key":"5883_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/art.20082","volume":"51","author":"D Bligny","year":"2004","unstructured":"Bligny D, Mahr A, Toumelin PL, Mouthon L, Guillevin L (2004) Predicting mortality in systemic Wegener\u2019s granulomatosis: a survival analysis based on 93 patients. Arthr Rheum 51(1):83\u201391","journal-title":"Arthr Rheum"},{"issue":"7","key":"5883_CR18","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/ndt\/gfac320","volume":"38","author":"B S\u00e1nchez \u00c1lamo","year":"2023","unstructured":"S\u00e1nchez \u00c1lamo B, Moi L, Bajema I, Faurschou M, Flossmann O, Hauser T et al (2023) Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis. Nephrol Dialy Transplant 38(7):1655\u20131665","journal-title":"Nephrol Dialy Transplant"},{"issue":"2","key":"5883_CR19","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00296-020-04752-9","volume":"41","author":"C Speer","year":"2021","unstructured":"Speer C, Altenm\u00fcller-Walther C, Splitthoff J, Nusshag C, K\u00e4lble F, Reichel P et al (2021) Glucocorticoid maintenance therapy and severe infectious complications in ANCA-associated vasculitis: a retrospective analysis. Rheumatol Int 41(2):431\u2013438","journal-title":"Rheumatol Int"},{"issue":"6","key":"5883_CR20","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/rheumatology\/keaa699","volume":"60","author":"J Rathmann","year":"2021","unstructured":"Rathmann J, Jayne D, Segelmark M, J\u00f6nsson G, Mohammad AJ (2021) Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study. Rheumatology (Oxford) 60(6):2745\u20132754","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"5883_CR21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/RHU.0000000000001855","volume":"28","author":"B \u0130nce","year":"2022","unstructured":"\u0130nce B, Bekta\u015f M, Koca N, A\u011farg\u00fcn BF, Zarali S, G\u00fczey DY et al (2022) Antineutrophil cytoplasmic antibody-associated vasculitis and COVID-19: The Clinical Course and prognosis of 15 patients from a tertiary care center. J clin rheumatol 28(6):300\u2013304","journal-title":"J clin rheumatol"},{"issue":"12","key":"5883_CR22","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s00296-022-05177-2","volume":"42","author":"J Samanta","year":"2022","unstructured":"Samanta J, Naidu G, Deo P, Mittal S, Prasad CB, Das D et al (2022) Managing ANCA-associated vasculitis during COVID-19 pandemic: a single-center cross-sectional study. Rheumatol Int 42(12):2159\u20132166","journal-title":"Rheumatol Int"},{"issue":"6","key":"5883_CR23","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s11926-012-0291-1","volume":"14","author":"K Bhamra","year":"2012","unstructured":"Bhamra K, Luqmani R (2012) Damage assessment in ANCA-associated vasculitis. Curr Rheumatol Rep 14(6):494\u2013500","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"5883_CR24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"GS Hoffman","year":"1992","unstructured":"Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD et al (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116(6):488\u2013498","journal-title":"Ann Intern Med"},{"issue":"1","key":"5883_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa020286","volume":"349","author":"D Jayne","year":"2003","unstructured":"Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadonien\u00e9 J et al (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349(1):36\u201344","journal-title":"N Engl J Med"},{"issue":"1","key":"5883_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1136\/ard.2009.122952","volume":"70","author":"R Suppiah","year":"2011","unstructured":"Suppiah R, Flossman O, Mukhtyar C, Alberici F, Baslund B, Brown D et al (2011) Measurement of damage in systemic vasculitis: a comparison of the Vasculitis damage index with the combined damage assessment index. Ann Rheum Dis 70(1):80\u201385","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5883_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15009","volume":"27","author":"N Ono","year":"2024","unstructured":"Ono N, Kai T, Takeyama Y, Inoue Y, Ueda N, Nagano S et al (2024) Recent advances in the treatment strategy for AAV improved outcomes with intensive GC tapering. Int J Rheum Dis 27(1):e15009","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"5883_CR28","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","volume":"382","author":"M Walsh","year":"2020","unstructured":"Walsh M, Merkel PA, Peh CA, Szpirt WM, Pu\u00e9chal X, Fujimoto S et al (2020) Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med 382(7):622\u2013631","journal-title":"N Engl J Med"},{"issue":"12","key":"5883_CR29","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1002\/art.42651","volume":"75","author":"JL Bloom","year":"2023","unstructured":"Bloom JL, Pickett-Nairn K, Silveira L, Fuhlbrigge RC, Cuthbertson D, Akuthota P et al (2023) The association between age at diagnosis and disease characteristics and damage in patients with ANCA-associated vasculitis. Arthr Rheumatol (Hoboken, NJ) 75(12):2216\u20132227","journal-title":"Arthr Rheumatol (Hoboken, NJ)"},{"issue":"9","key":"5883_CR30","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/ndt\/gfae018","volume":"39","author":"B Sachez-Alamo","year":"2024","unstructured":"Sachez-Alamo B, Moi L, Bajema I, Berden A, Flossmann O, Hruskova Z et al (2024) Long-term outcome of kidney function in patients with ANCA-associated vasculitis. Nephrol Dialys Transplant 39(9):1483\u20131493","journal-title":"Nephrol Dialys Transplant"},{"issue":"12","key":"5883_CR31","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1093\/rheumatology\/ker266","volume":"50","author":"R Suppiah","year":"2011","unstructured":"Suppiah R, Hadden RD, Batra R, Arden NK, Collins MP, Guillevin L et al (2011) Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials. Rheumatology (Oxford) 50(12):2214\u20132222","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5883_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.berh.2012.12.003","volume":"27","author":"A Mahr","year":"2013","unstructured":"Mahr A, Heijl C, Le Guenno G, Faurschou M (2013) ANCA-associated vasculitis and malignancy: current evidence for cause and consequence relationships. Best Pract Res Clin Rheumatol 27(1):45\u201356","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"5883_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00002281-199701000-00014","volume":"9","author":"GM Mody","year":"1997","unstructured":"Mody GM, Cassim B (1997) Rheumatologic manifestations of malignancy. Curr Opin Rheumatol 9(1):75\u201379","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"5883_CR34","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s10238-024-01475-0","volume":"24","author":"L Li","year":"2024","unstructured":"Li L, Teng J, Kou N, Yue Y, Wang H (2024) ANCA-associated vasculitis and lung cancer: an immunological perspective. Clin Exp Med 24(1):208","journal-title":"Clin Exp Med"},{"issue":"11","key":"5883_CR35","first-page":"2752","volume":"68","author":"JA Avi\u00f1a-Zubieta","year":"2016","unstructured":"Avi\u00f1a-Zubieta JA, Mai A, Amiri N, Dehghan N, Ann Tan J, Sayre EC et al (2016) Risk of myocardial infarction and stroke in patients with granulomatosis with polyangiitis (Wegener\u2019s): a population-based study. Arthr Rheumatoo (Hoboken, NJ) 68(11):2752\u20132759","journal-title":"Arthr Rheumatoo (Hoboken, NJ)"},{"issue":"5","key":"5883_CR36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.mayocp.2018.02.010","volume":"93","author":"A Berti","year":"2018","unstructured":"Berti A, Matteson EL, Crowson CS, Specks U, Cornec D (2018) Risk of cardiovascular disease and venous thromboembolism among patients with incident ANCA-associated vasculitis: A 20-Year Population-Based Cohort Study. Mayo Clin Proc 93(5):597\u2013606","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"5883_CR37","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.semarthrit.2017.07.004","volume":"47","author":"YH Bai","year":"2018","unstructured":"Bai YH, Li ZY, Chang DY, Chen M, Kallenberg CG, Zhao MH (2018) The BVAS is an independent predictor of cardiovascular events and cardiovascular disease-related mortality in patients with ANCA-associated vasculitis: a study of 504 cases in a single Chinese center. Semin Arthr Rheum 47(4):524\u2013529","journal-title":"Semin Arthr Rheum"},{"issue":"1","key":"5883_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12959-024-00593-9","volume":"22","author":"X Chen","year":"2024","unstructured":"Chen X, Zhang S, You R, Ma Y, Xia P, Shi X et al (2024) Renal damage and old age: risk factors for thrombosis in patients with ANCA-associated vasculitis. Thromb J 22(1):29","journal-title":"Thromb J"},{"issue":"5","key":"5883_CR39","first-page":"704","volume":"56","author":"A Kronbichler","year":"2017","unstructured":"Kronbichler A, Leierer J, Leierer G, Mayer G, Casian A, H\u00f6glund P et al (2017) Clinical associations with venous thromboembolism in anti-neutrophil cytoplasm antibody-associated vasculitides. Rheumatology (Oxford) 56(5):704\u2013708","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"5883_CR40","doi-asserted-by":"publisher","first-page":"620","DOI":"10.7326\/0003-4819-142-8-200505030-00011","volume":"142","author":"PA Merkel","year":"2005","unstructured":"Merkel PA, Lo GH, Holbrook JT, Tibbs AK, Allen NB, Davis JC Jr et al (2005) Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener\u2019s Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med 142(8):620\u2013626","journal-title":"Ann Intern Med"},{"issue":"6","key":"5883_CR41","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/BF02238558","volume":"15","author":"SE Gusis","year":"1996","unstructured":"Gusis SE, Milozzi P, Maldonado Cocco JA (1996) Osteonecrosis in Churg-Strauss allergic vasculitis. Clin Rheumatol 15(6):622\u2013623","journal-title":"Clin Rheumatol"},{"issue":"1","key":"5883_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002787","volume":"9","author":"N Mimura","year":"2023","unstructured":"Mimura N, Iwamoto T, Furuta S, Ikeda K, Kobayashi Y, Nakamura T et al (2023) Prevalence and risk factors of osteonecrosis of the femoral head in patients with ANCA-associated vasculitis: a multicentre cohort study. RMD Open. 9(1):e002787","journal-title":"RMD Open."}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05883-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-05883-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05883-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T13:03:37Z","timestamp":1748005417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-05883-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["5883"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-05883-7","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no conflicts of interest, including any financial support from industry or government institutions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional Review Board approval was obtained from the Istanbul Faculty of Medicine Ethics Committee for this study (date and number: 06\/07\/2020-75926).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"137"}}